1Coviello AD,Legro RS,Dunaif A. Adolescent grils with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androngen levels independent of obesity and insulin resistance[J]. Clin Endocrinol Metab,2006,91(2) :492 - 497
2Laven JS,Imani B,Eijkemans MJ,et al. New approaches to PCOS and other froms of anovulation[J]. Obstet Gynecol Surv,2002,57(11) :755 - 767
3Deugarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment[J]. Fertil Sterl, 2005,83 (5) : 1454 - 1460
4Ducluzeau PH,Cousin P,Malvoisin E,et al. Glucose- to- insulin ratio rather than sex hormonebinding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women polyeystic ovary syndrome[J].Clin Endocrinol Metab,2003,88(8) t3626 - 3631
5Seli E, Duleba AJ. Should patients with polycystic ovarian syndrome be treated with metformin[J].Hum Reprod,2002, 17(9) :2230 - 2236
6Kacalska O, Krzyezkowska - Sendrakowska M, Milewicz T. Molecular action of inslinsensitizing agents[J]. Endokrynol Pol,2005,56(3):308 - 313
8Hardiman P, Pillay OS, Atioma W. Polycystic ovary syndrome and endometrial carcinoma[J]. Lancet, 2003,361(9371) : 1801 - 1812
9Jeffrey C, Mickey S, Co filer. Polycystic ovary syndrome: early detection in the adolescent[J]. Clin Obstet Gynecol, 2007,50 (1):178- 187
10Segal KR,Dunaif A. Resting mebolie rate and postprandial thermogenesis in polyeystic syndrome[J]. Int J Obes,1990,14:559 - 567
二级参考文献33
1Kaaijk EM,Sasano H,Suzuki T,et al. Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study.Mol Hum Reprod, 2000,6:443-447.
2Pirwany IR, Yates RW, Cameron IT, et al. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.Hum Reprod, 1999,14:2963-2968.
4Greenblatt E, Casper RF. Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome. Am J Obstet Gynecol,1987,42:517-518.
5Rossmanith WG, Keckstein J, Spatzier K, et al. The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease.Clin Endocrinol,1991,34:223-230.
6Sumioki H, Utsunomiya T. Ovarian drilling. In: Kempers R, Cohen J, Haney AF, et al, eds. Fertility and reproduction medicine. New York: Elsevier Science,1998.537-539.
7Tropeano G, Liberale I, Vuolo IP, et al. Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome. J Endocrinol Invest, 1997,20:220-224.
8Young RH. Dusting off old books: comments on classic gynecologic pathology books of yesteryear.Int J Gynecol Pathol, 2000,19:67-84.
9Ferraretti AP, Gianaroli L, Magli MC, et al. Transvaginal ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome.Fertil Steril, 2001,76:812-816.
10Russell JB, Knezevich KM, Fabian KF,et al. Unstimulated immature oocyte retrieval: early versus midfollicular endometrial priming.Fertil Steril, 1997,67:616-620.
